#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurodermatitis Chorioretinitis Leiomyosarcoma metastatic Hepato-lenticular degeneration Short stature homeobox gene mutation Erythema multiforme Stress cardiomyopathy Hepatitis B B-cell lymphoma refractory Mitochondrial DNA depletion Transitional cell cancer of the renal pelvis and ureter Huntington's disease Thrombotic microangiopathy Malformation venous Epstein-Barr virus associated lymphoproliferative disorder More trials…

    Learn about Rare Diseases

    Propionic acidaemia – Life with Disease Haemophilia B without inhibitors – Diagnostics Epidermolysis bullosa – Trials in Disease Hairy cell leukaemia – Basic Information Bronchopulmonary dysplasia – Basic Information Synovial sarcoma metastatic – Trials in Disease Breast angiosarcoma – Treatment Shprintzen-Goldberg syndrome – Life with Disease Immunodeficiency congenital – Life with Disease Glomerulonephritis membranoproliferative – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Neob TAGRAXOFUSP Toripalimab Vericiguat Baricitinib Forimtamig ROPINIROLE Op-1250 Triamcinolone Acetonide Cdr132L Sodium S-241656 Ttx-030 Batoclimab Interferon Gamma Corline Heparin Conjugate GSKVX000000048111 Idecabtagene Vicleucel Treprostinil PIPOTIAZINE Pilocarpine Hydrochloride More therapies…

    Learn about Your Condition

    Tachypnoea Lymphangioleiomyomatosis Acute kidney injury Dementia Alzheimer's type Ependymoma Thyroid cancer metastatic Mantle cell lymphoma stage IV Juvenile idiopathic arthritis Genitourinary tract neoplasm Elderly Meniscus operation Spina bifida Chronic myeloid leukaemia ROHHAD syndrome Herpes virus infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Oropharyngeal squamous cell carcinoma

  • Study on the Safety and Effectiveness of Afatinib for Fanconi Anemia Patients with Advanced Squamous Cell Carcinoma in the Oral Cavity, Oropharynx, Hypopharynx, or Larynx

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital aplastic anaemia
    • Oropharyngeal squamous cell carcinoma
    • Squamous cell carcinoma of the oral cavity
    Investigated Drugs:
    • Afatinib
    Germany Spain

  • Study on Reducing Treatment Intensity for Patients with HPV-Positive Oropharyngeal Cancer Using Cisplatin and Carboplatin

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Oropharyngeal squamous cell carcinoma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    France Germany

  • Study of Pembrolizumab with Lenvatinib after Chemoradiation Treatment in Patients with Locally Advanced Head and Neck Cancer who are PD-L1 Positive

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Oropharyngeal squamous cell carcinoma
    • Squamous cell carcinoma of the oral cavity
    • Laryngeal squamous cell carcinoma
    Investigated Drugs:
    • Lenvatinib
    • Pembrolizumab
    Germany

  • Study on Reducing Chemoradiotherapy for HPV-Related Oropharyngeal Cancer Using Cisplatin for Patients with Squamous Cell Carcinoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Oropharyngeal squamous cell carcinoma
    Investigated Drugs:
    • Cisplatin
    Slovakia

  • Study on Niraparib and Dostarlimab for Patients with HPV-Negative Head and Neck Squamous Cell Carcinoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Niraparib
    • Dostarlimab
    Italy

  • Study Comparing Cisplatin and Radiotherapy with Durvalumab and Radiotherapy for Patients with Intermediate Risk HPV-Positive Oropharyngeal Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Cisplatin
    • Durvalumab
    Belgium Italy Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!